Erratum: Clinical picture and risk prediction of short-term mortality in cardiogenic shock (European Journal of Heart Failure (2015) 17:5 (501-509) DOI:10.1002/ejhf.260);Clinical picture and risk prediction of short-term mortality in cardiogenic shock

European Journal of Heart Failure

Volumn 17, Issue 5, 2015, Pages 501-509

  Harjola, Veli Pekka ^a   Lassus, Johan ^a   Sionis, Alessandro ^b   Køber, Lars ^c   Tarvasmäki, Tuukka ^a   Spinar, Jindrich ^d   Parissis, John ^e   Banaszewski, Marek ^f   Silva Cardoso, Jose ^g   Carubelli, Valentina ^h   Di Somma, Salvatore ⁱ   Tolppanen, Heli ^a   Zeymer, Uwe ^j   Thiele, Holger ^k   Nieminen, Markku S ^a   Mebazaa, Alexandre ^l  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c Rigshospitalet   (Denmark)

^d UNIVERSITY HOSPITAL BRNO   (Czech Republic)

^e NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^f INSTITUTE OF CARDIOLOGY   (Poland)

^g UNIVERSITY OF PORTO   (Portugal)

^h Department of Medical and Surgical Specialties Radiological Sciences and Public Health University and Civil Hospitals of Brescia   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j KLINIKUM LUDWIGSHAFEN   (Germany)

^k UNIVERSITY OF LÜBECK   (Germany)

^l HÔPITAL LARIBOISIÈRE   (France)

more..

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Cardiogenic shock; Management; Prognosis; Risk score

Indexed keywords

LACTIC ACID;

ACUTE CORONARY SYNDROME; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CARDSHOCK RISK SCORE; CONFUSION; CORONARY ARTERY BYPASS SURGERY; DISEASE SEVERITY; FEMALE; FLUID RESUSCITATION; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPOTENSION; INTENSIVE CARE; LACTATE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MEDICAL DECISION MAKING; MULTICENTER STUDY; OBSERVATIONAL STUDY; PATIENT SELECTION; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SYSTOLIC BLOOD PRESSURE; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; MORTALITY; RISK FACTOR; SHOCK, CARDIOGENIC; VALVULAR HEART DISEASE;

ACUTE CORONARY SYNDROME; AGED; CORONARY ANGIOGRAPHY; FEMALE; HEART FAILURE; HEART VALVE DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC;

EID: 84928470973     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.349     Document Type: Erratum

References (26)

1. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, Bonzel T, Senges J, Neuhaus KL, Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J 2004; 25: 322-328.
2. Jeger RV, Radovanovic D, Hunziker PR, Pfisterer ME, Stauffer JC, Erne P, Urban P, AMIS Plus Registry Investigators. Ten-year trends in the incidence and treatment of cardiogenic shock. Ann Intern Med 2008; 149: 618-626.
3. Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J,. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009; 119: 1211-1219.
4. Aissaoui N, Puymirat E, Tabone X, Charbonnier B, Schiele F, Lefevre T, Durand E, Blanchard D, Simon T, Cambou JP, Danchin N,. Improved outcome of cardiogenic shock at the acute stage of myocardial infarction: a report from the USIK 1995, USIC 2000, and FAST-MI French nationwide registries. Eur Heart J 2012; 33: 2535-2543.
5. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH,. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 1999; 341: 625-634.
6. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blomstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D,. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619.
7. Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Juni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A, Authors/Task Force members. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541-2619.
8. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
9. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Fuhrmann J, Bohm M, Ebelt H, Schneider S, Schuler G, Werdan K, IABP-SHOCK II, Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367: 1287-1296.
10. Topalian S, Ginsberg F, Parrillo JE,. Cardiogenic shock. Crit Care Med 2008; 36: S66-S74.
11. Gowda RM, Fox JT, Khan IA,. Cardiogenic shock: basics and clinical considerations. Int J Cardiol 2008; 123: 221-228.
12. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
13. Sleeper LA, Reynolds HR, White HD, Webb JG, Dzavik V, Hochman JS,. A severity scoring system for risk assessment of patients with cardiogenic shock: a report from the SHOCK Trial and Registry. Am Heart J 2010; 160: 443-450.
14. Knaus WA, Draper EA, Wagner DP, Zimmerman JE,. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-829.
15. Reynolds HR, Hochman JS,. Cardiogenic shock: current concepts and improving outcomes. Circulation 2008; 117: 686-697.
16. Kellner P, Prondzinsky R, Pallmann L, Siegmann S, Unverzagt S, Lemm H, Dietz S, Soukup J, Werdan K, Buerke M,. Predictive value of outcome scores in patients suffering from cardiogenic shock complicating AMI: APACHE II, APACHE III, Elebute-Stoner, SOFA, and SAPS II. Med Klin Intensivmed Notfmed 2013; 108: 666-674.
17. Prondzinsky R, Lemm H, Swyter M, Wegener N, Unverzagt S, Carter JM, Russ M, Schlitt A, Buerke U, Christoph A, Schmidt H, Winkler M, Thiery J, Werdan K, Buerke M,. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med 2010; 38: 152-160.
18. De Backer D, Biston P, Devriendt J, Madl C, Chochrad D, Aldecoa C, Brasseur A, Defrance P, Gottignies P, Vincent JL, SOAP II, Investigators. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010; 362: 779-789.
19. Levy B, Perez P, Perny J, Thivilier C, Gerard A,. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med 2011; 39: 450-455.
20. Zannad F, Mebazaa A, Juilliere Y, Cohen-Solal A, Guize L, Alla F, Rouge P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K, for the EFICA Investigators. Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 2006; 8: 697-705.
21. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, de Waha A, Richardt G, Hennersdorf M, Empen K, Fuernau G, Desch S, Eitel I, Hambrecht R, Lauer B, Bohm M, Ebelt H, Schneider S, Werdan K, Schuler G, on behalf of the Intraaortic Balloon Pump in cardiogenic shock II (IABP-SHOCK II) trial investigators. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 2013; 382: 1638-1645.
22. Klein LW, Shaw RE, Krone RJ, Brindis RG, Anderson HV, Block PC, McKay CR, Hewitt K, Weintraub WS, American College of Cardiology National Cardiovascular Data Registry. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model. Am J Cardiol 2005; 96: 35-41.
23. Katz JN, Stebbins AL, Alexander JH, Reynolds HR, Pieper KS, Ruzyllo W, Werdan K, Geppert A, Dzavik V, Van de Werf F, Hochman JS, TRIUMPH Investigators. Predictors of 30-day mortality in patients with refractory cardiogenic shock following acute myocardial infarction despite a patent infarct artery. Am Heart J 2009; 158: 680-687.
24. Garcia-Alvarez A, Arzamendi D, Loma-Osorio P, Kiamco R, Masotti M, Sionis A, Betriu A, Brugada J, Bosch X,. Early risk stratification of patients with cardiogenic shock complicating acute myocardial infarction who undergo percutaneous coronary intervention. Am J Cardiol 2009; 103: 1073-1077.
25. Sander O, Welters ID, Foëx P, Sear JW,. Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications. Crit Care Med 2005; 33: 81-88.
26. Vincent JL, Moreno R,. Clinical review: scoring systems in the critically ill. Crit Care 2010; 14: 207.